Western Blot: CD69 Antibody (15B5G2) [NBP2-25236] - Analysis using Azide Free version of NBP2-25236. CD69 in A) a partial recombinant protein and B) ThP1 lysate using CD69 antibody at 0.5 ug/ml. goat anti-mouse Ig HRP ...read more
Immunohistochemistry-Paraffin: CD69 Antibody (15B5G2) [NBP2-25236] - Analysis using Azide Free version of NBP2-25236. Formalin-fixed, paraffin-embedded human tonsil stained with CD69 antibody (1 ug/ml), ...read more
Western Blot: CD69 Antibody (15B5G2) [NBP2-25236] - analysis of CD69 in A) a partial recombinant protein and B) ThP1 lysate using CD69 antibody at 0.5 ug/ml. Goat anti-mouse Ig HRP secondary antibody and PicoTect ECL ...read more
Immunohistochemistry-Paraffin: CD69 Antibody (15B5G2) [NBP2-25236] - Formalin-fixed, paraffin-embedded human tonsil stained with CD69 antibody (1 ug/ml), peroxidase-conjugate and DAB chromogen.
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
0.2 ml PBS and 0.05% BSA
0.05% Sodium Azide
Protein G purified
Alternate Names for CD69 Antibody (15B5G2)
activation inducer molecule (AIM/CD69)
Activation inducer molecule
CD69 antigen (p60, early T-cell activation antigen)
CLEC2CC-type lectin domain family 2 member C
C-type lectin domain family 2, member C
early activation antigen CD69
early lymphocyte activation antigen
Early T-cell activation antigen p60
Leukocyte surface antigen Leu-23
CD69 is a transmembrane C-type lectin broadly expressed on the cell surface of activated leukocytes, including T and B lymphocytes, neutrophils, natural killer cells, and eosinophils, and is constitutively expressed on the surface of monocytes and platelets (Vance BA et al., 2005 15893733). The abundance of CD69 rapidly increases after cell activation in all bone marrow-derived cells except erythrocytes (Martin P et al., 2011 21427408). It is an earliest lymphocyte activation antigen and a universal leukocyte triggering molecule expressed at sites of active immune response (Kavan D et al., 2010 20369839). CD69 plays a key role in early inflammation and modulation of adaptive immune responses through the production of a variety of cytokines and lymphocyte migration. Expression of CD69 has been observed in human diseases. Moreover anti-CD69 monoclonal antibodies have therapeutic effect in the treatment process of different animal models of cancer and autoimmune disorders (Vazquez BN et al., 2012 22456278). Surface-expressed CD69 is an activation marker for basophils and is strongly induced by IL-3. Upregulated CD69 expression on locally accumulated basophils in bronchial asthma attributed at least in part to a combination of local cytokines, especially IL-3, plus exposure to low levels of IgE-crosslinking allergens (Suzukawa M et al., 2007 17541278).
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.